Multiple Dose Pharmacokinetics of Four Different Doses of Nisoldipine in Hypertensive Patients-Reference-Cited by-同舟云学术

Multiple Dose Pharmacokinetics of Four Different Doses of Nisoldipine in Hypertensive Patients

Published:1992-06 Issue:6 Volume:32 Page:571-575
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Chandler Mary H. H.,Clifton G. Dennis,Lettieri John T.,Mazzu Arthur L.,Allington Douglas R.,Thieneman Andrew C.,Foster Thomas S.,Harrison Michael R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

1. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-di-methyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (nisoldipine, Bay k 5552);Kazda;Arzneim-Forsch/Drug Res,1980

2. New calcium antagonists: Relevance of vasoselectivity;Parmley;Am Heart J,1990

3. Bioequivalence of different nitrendipine tablet dosage formulations;Krol;J Cardiovasc Pharmacol,1987

4. Pharmacokinetics of nisoldipine III. Biotransformation of nisoldipine in rat, dog, monkey, and man;Scherling;Arzneim-Forsch/Drug Res,1988

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Interaction between Nisoldipine and Repaglinide in Rats;Biomolecules and Therapeutics;2011-10-30

2. LIQUID CHROMATOGRAPHY/POSITIVE-ION ELECTROSPRAY TANDEM MASS SPECTROMETRY ASSAY FOR NISOLDIPINE IN HUMAN PLASMA AND ITS APPLICATION TO A PHARMACOKINETIC STUDY;Journal of Liquid Chromatography & Related Technologies;2011-09-22

3. Pharmacologic Agents in the Management of Hypertension-Nisoldipine Coat-Core;The Journal of Clinical Hypertension;2007-05-09

4. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment;Food and Chemical Toxicology;2003-02

5. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus;European Journal of Clinical Pharmacology;2002-12-01